BNTC Stock Summary and Trading Ideas (Benitec Biopharma | NASDAQ:BNTC)

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.

Benitec Biopharma trades on the NASDAQ stock market under the symbol BNTC.

As of October 29, 2026, BNTC stock price climbed to $8.83 with 155,122 million shares trading.

BNTC has a beta of 2.36, meaning it tends to be more sensitive to market movements. BNTC has a correlation of 0.23 to the broad based SPY ETF.

BNTC has a market cap of $308.01 million. This is considered a Small Cap stock.

In the last 3 years, BNTC traded as high as $17.15 and as low as $2.69.

The top ETF exchange traded funds that BNTC belongs to (by Net Assets): PINK, VTI, IWM, VXF, IWN.

BNTC has underperformed the market in the last year with a return of -45.4%, while the SPY ETF gained +13.1%. In the last 3 month period, BNTC fell short of the market, returning -25.7%, while SPY returned +4.1%. However, in the most recent 2 weeks BNTC has outperformed the stock market by returning +6.5%, while SPY returned 0.0%.

BNTC support price is $8.34 and resistance is $9.26 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BNTC shares will trade within this expected range on the day.